The Federal Government has said the extract of the plant used for the herbal drug produced by the Republic of Madagascar for the prevention and cure of coronavirus (COVID-19), grows in the country.
The Minister of Health, Dr. Osagie Ehanire, said this on Monday in Abuja, while answering questions, at the 29th joint national briefing of the Presidential Taskforce on COVID-19.
According to him, the herbal drug will be subjected to analysis by the National Institute for Pharmaceutical Research and Development (NIPRD) to determine its efficacy and safety before it can be adopted for the treatment of COVID-19.
"We are going to get samples of the herb of the botanical product for analyses and also probably use that opportunity to speak with the health authorities there particularly the scientific community on how they use it. We will also give it to the research community here with us to examine and see what they can do with it.
“We understand that it is something called Artemisia Annua, which also grows here. But we would like to get that sample and compare it with the strain here to know if they are exactly identical or similar and then see what properties it has.
“It will be subjected to analysis to find out what works in there and how it works and is used in getting a cure. All countries around the world are interested in finding a cure and we are not different. So, we will look at all options and promises that have been made.
"Before we give any of these medicines to our people, we will make sure they are actually safe and that they work,” Ehanire said.
The Madagascar President, Andry Rajoelina, had officially launched a locally produced medicine he believes can prevent and cure patients suffering from COVID-19 ailment.
The drug was developed by the Malagasy Institute of Applied Research and branded COVID Organics.
The Minister of Health, Dr. Osagie Ehanire, said this on Monday in Abuja, while answering questions, at the 29th joint national briefing of the Presidential Taskforce on COVID-19.
According to him, the herbal drug will be subjected to analysis by the National Institute for Pharmaceutical Research and Development (NIPRD) to determine its efficacy and safety before it can be adopted for the treatment of COVID-19.
"We are going to get samples of the herb of the botanical product for analyses and also probably use that opportunity to speak with the health authorities there particularly the scientific community on how they use it. We will also give it to the research community here with us to examine and see what they can do with it.
“We understand that it is something called Artemisia Annua, which also grows here. But we would like to get that sample and compare it with the strain here to know if they are exactly identical or similar and then see what properties it has.
“It will be subjected to analysis to find out what works in there and how it works and is used in getting a cure. All countries around the world are interested in finding a cure and we are not different. So, we will look at all options and promises that have been made.
"Before we give any of these medicines to our people, we will make sure they are actually safe and that they work,” Ehanire said.
The Madagascar President, Andry Rajoelina, had officially launched a locally produced medicine he believes can prevent and cure patients suffering from COVID-19 ailment.
The drug was developed by the Malagasy Institute of Applied Research and branded COVID Organics.